Self-regulation of autologous cell therapies

Bernard E. Tuch; Dominic M. Wall

doi:10.5694/mja13.11043

Self-regulation of autologous cell therapies

Bernard E. Tuch, Dominic M. Wall

Research output: Contribution to journal › Comment / Debate › Other › peer-review

9 Citations (Scopus)

Abstract

A first step for a virtually unregulated industry Autologous cell therapies are being used privately by increasing numbers of clinicians to treat a number of disorders including rheumatological conditions, sports injuries, strokes, Parkinson disease and multiple sclerosis. Sources of cells include stromal vascular fractions obtained during liposuction which contain mesenchymal stem cells, as well as platelet rich plasma obtained from peripheral blood.

Original language	English
Pages (from-to)	196
Number of pages	1
Journal	The Medical Journal of Australia
Volume	200
Issue number	4
DOIs	https://doi.org/10.5694/mja13.11043
Publication status	Published - 3 Mar 2014

Access to Document

10.5694/mja13.11043

Cite this

@article{50ba778ccc0c4a1ba61d5c777ab0a16f,

title = "Self-regulation of autologous cell therapies",

abstract = "A first step for a virtually unregulated industry Autologous cell therapies are being used privately by increasing numbers of clinicians to treat a number of disorders including rheumatological conditions, sports injuries, strokes, Parkinson disease and multiple sclerosis. Sources of cells include stromal vascular fractions obtained during liposuction which contain mesenchymal stem cells, as well as platelet rich plasma obtained from peripheral blood.",

author = "Tuch, {Bernard E.} and Wall, {Dominic M.}",

year = "2014",

month = mar,

day = "3",

doi = "10.5694/mja13.11043",

language = "English",

volume = "200",

pages = "196",

journal = "The Medical Journal of Australia",

issn = "0025-729X",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Self-regulation of autologous cell therapies

AU - Tuch, Bernard E.

AU - Wall, Dominic M.

PY - 2014/3/3

Y1 - 2014/3/3

N2 - A first step for a virtually unregulated industry Autologous cell therapies are being used privately by increasing numbers of clinicians to treat a number of disorders including rheumatological conditions, sports injuries, strokes, Parkinson disease and multiple sclerosis. Sources of cells include stromal vascular fractions obtained during liposuction which contain mesenchymal stem cells, as well as platelet rich plasma obtained from peripheral blood.

AB - A first step for a virtually unregulated industry Autologous cell therapies are being used privately by increasing numbers of clinicians to treat a number of disorders including rheumatological conditions, sports injuries, strokes, Parkinson disease and multiple sclerosis. Sources of cells include stromal vascular fractions obtained during liposuction which contain mesenchymal stem cells, as well as platelet rich plasma obtained from peripheral blood.

UR - http://www.scopus.com/inward/record.url?scp=84899154565&partnerID=8YFLogxK

U2 - 10.5694/mja13.11043

DO - 10.5694/mja13.11043

M3 - Comment / Debate

C2 - 24580511

AN - SCOPUS:84899154565

SN - 0025-729X

VL - 200

SP - 196

JO - The Medical Journal of Australia

JF - The Medical Journal of Australia

IS - 4

ER -

Self-regulation of autologous cell therapies

Abstract

Access to Document

Other files and links

Cite this